NutriSystem (NTRI) Lifted to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of NutriSystem (NASDAQ:NTRI) from a hold rating to a buy rating in a research note published on Tuesday morning. They currently have $58.00 price objective on the stock.

According to Zacks, “Nutrisystem, Inc. is a leader in the weight loss industry, having helped millions of people loses weight. From the flagship Nutrisystem brand comes the clinically-tested Nutrisystem Lean13 program, designed to deliver weight loss of up to 13 pounds and seven inches in the first month. South Beach Diet became an all-new structured meal delivery weight-loss program following the acquisition of the brand. Additional Nutrisystem branded weight-loss products include Fast 5 and Turbo 10, as well as multi-day kits and individual products at select retail outlets. “

NTRI has been the subject of several other reports. B. Riley set a $74.00 price objective on shares of NutriSystem and gave the stock a buy rating in a research report on Thursday, October 26th. BidaskClub cut shares of NutriSystem from a buy rating to a hold rating in a research report on Saturday, August 26th. Finally, Lake Street Capital set a $73.00 price target on shares of NutriSystem and gave the company a buy rating in a research report on Thursday, October 26th. Two equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The stock presently has a consensus rating of Buy and an average price target of $67.56.

NutriSystem (NASDAQ NTRI) traded up $0.15 during trading on Tuesday, hitting $54.10. 311,700 shares of the stock traded hands, compared to its average volume of 487,349. The stock has a market cap of $1,620.63, a PE ratio of 29.48, a P/E/G ratio of 1.51 and a beta of 1.01. NutriSystem has a 1-year low of $31.60 and a 1-year high of $67.95.

NutriSystem (NASDAQ:NTRI) last released its quarterly earnings data on Wednesday, October 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.46 by $0.03. The business had revenue of $158.10 million during the quarter, compared to analysts’ expectations of $155.21 million. NutriSystem had a net margin of 8.27% and a return on equity of 49.69%. The company’s revenue for the quarter was up 26.9% on a year-over-year basis. During the same period in the previous year, the company earned $0.27 EPS. analysts anticipate that NutriSystem will post 1.95 earnings per share for the current year.

NutriSystem announced that its Board of Directors has authorized a share repurchase plan on Wednesday, October 25th that authorizes the company to repurchase $50.00 million in shares. This repurchase authorization authorizes the company to purchase shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company’s board of directors believes its shares are undervalued.

In other NutriSystem news, insider Dawn M. Zier sold 11,000 shares of NutriSystem stock in a transaction on Thursday, December 14th. The shares were sold at an average price of $49.94, for a total value of $549,340.00. Following the transaction, the insider now directly owns 210,666 shares in the company, valued at $10,520,660.04. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Keira Krausz sold 10,000 shares of NutriSystem stock in a transaction on Monday, December 11th. The shares were sold at an average price of $51.20, for a total transaction of $512,000.00. Following the completion of the transaction, the insider now owns 74,519 shares in the company, valued at $3,815,372.80. The disclosure for this sale can be found here. Over the last three months, insiders sold 36,134 shares of company stock valued at $1,913,045. 2.40% of the stock is owned by corporate insiders.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. increased its stake in NutriSystem by 50.3% in the second quarter. Vanguard Group Inc. now owns 2,458,686 shares of the company’s stock valued at $127,974,000 after purchasing an additional 823,221 shares during the period. Prudential Financial Inc. increased its stake in NutriSystem by 73.7% in the second quarter. Prudential Financial Inc. now owns 1,302,467 shares of the company’s stock valued at $67,794,000 after purchasing an additional 552,420 shares during the period. Marshall Wace North America L.P. acquired a new position in NutriSystem in the second quarter valued at $1,823,000. Cubist Systematic Strategies LLC increased its stake in NutriSystem by 130.5% in the second quarter. Cubist Systematic Strategies LLC now owns 17,560 shares of the company’s stock valued at $914,000 after purchasing an additional 9,942 shares during the period. Finally, Assetmark Inc. increased its stake in NutriSystem by 13.0% in the second quarter. Assetmark Inc. now owns 125,103 shares of the company’s stock valued at $6,512,000 after purchasing an additional 14,358 shares during the period. Institutional investors own 92.48% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://www.com-unik.info/2017/12/22/nutrisystem-ntri-lifted-to-buy-at-zacks-investment-research.html.

About NutriSystem

Nutrisystem, Inc is a provider of weight management products and services, including nutritionally balanced weight loss programs, multi-day kits available at retail locations and digital tools to support weight loss. The Company’s program customers purchase monthly food packages containing four-week meal plan consisting supply of breakfasts, lunches, dinners and snacks and flex meal plan recipes, which they supplement with fresh fruits, vegetables and dairy.

Get a free copy of the Zacks research report on NutriSystem (NTRI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for NutriSystem (NASDAQ:NTRI)

What are top analysts saying about NutriSystem? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for NutriSystem and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit